Clostridium Difficile Carriage and Its Implications in Preoperative Colorectal Cancer Patients.

Yi Zheng,Peng Zhao,Weiqin Jiang,Lulu Liu,Zhou Tong,Dazhi Jin,Weijia Jia Fang
DOI: https://doi.org/10.1200/jco.2016.34.15_suppl.e15084
IF: 45.3
2016-01-01
Journal of Clinical Oncology
Abstract:e15084 Background: Clostridium difficile (C. difficile) colonizes the large intestine, with toxigenic strains causing infection resulting in serious morbidity and mortality, which has emerged as a worldwide health-care threat. Cancer is a known risk factor for C. difficile infection. Although the whole process of colonization to infection takes place in the large intestine, the real carriage pattern of C. difficile in preoperative colorectal cancer (CRC) patients has not been studied. Herein, we conduct this pilot study in order to reveal the potential relationship between C. difficile carriage and CRC patients who were scheduled to accept surgical resection. Methods: Stool samples from 206 preoperative CRC patients were collected in this study. Bacterial genomic DNA was extracted and two toxin genes (tcdA and tcdB) were detected. The clinical and pathology results of CRC patients were then collected for further analysis. Results: Thirty-three (16.0%) samples from preoperative CRC patients were confirmed to be C. difficile positive. CRC patients over 60 years old had a C. difficile positive rate as high as 18.2%. In contrast, patients who were younger than 60 years old had a C. difficile positive rate of only 12.2% (p = 0.02). Strikingly, the C. difficile positive rate for T4 and non-T4 CRC patients was 23.6% and 13.2% (p = 0.01), while C. difficile positive rate for lymph nodes (LN) positive and LN negative patients was 22.3% and 10.7%, respectively (p = 0.02). Meanwhile, stool occult blood (OB) negative CRC patients had a higher C. difficile positive rate than OB positive patients (24.0% to 11.5%, p = 0.02). No association was found between C. difficile carriage and cancer sites, macroscopic morphology, differentiation, and days of hospitalization. Conclusions: T4 or LN positive preoperative CRC patients have higher risk of C. difficile carriage. Since these patients inevitably need adjuvant chemotherapy, the call for sustained monitoring of C. difficile carriage is apparently urgent in order to avoid discontinuation of chemotherapy. Besides, elderly or OB negative preoperative CRC patients should also be noticed for potential C. difficile carriage.
What problem does this paper attempt to address?